Literature DB >> 31087267

The complexity of using resting myocardial perfusion to assess myocardial viability and predict functional recovery.

Jennifer K Lang1,2, John M Canty3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31087267      PMCID： PMC6851455          DOI： 10.1007/s12350-019-01742-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  20 in total

1.  Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment.

Authors:  Joseph B Selvanayagam; Michael Jerosch-Herold; Italo Porto; David Sheridan; Adrian S H Cheng; Steffen E Petersen; Nick Searle; Keith M Channon; Adrian P Banning; Stefan Neubauer
Journal:  Circulation       Date:  2005-11-14       Impact factor: 29.690

2.  The utility of 82Rb PET for myocardial viability assessment: Comparison with perfusion-metabolism 82Rb-18F-FDG PET.

Authors:  Jonathan B Moody; Keri M Hiller; Benjamin C Lee; Alexis Poitrasson-Rivière; James R Corbett; Richard L Weinberg; Venkatesh L Murthy; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2019-02-26       Impact factor: 5.952

3.  Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.

Authors:  Mark A Stankewicz; Craig S Mansour; Robert L Eisner; Keith B Churchwell; Byron R Williams; Steven R Sigman; James Streeter; Randolph E Patterson
Journal:  J Nucl Med       Date:  2005-10       Impact factor: 10.057

4.  18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium.

Authors:  J A Fallavollita; B J Perry; J M Canty
Journal:  Circulation       Date:  1997-04-01       Impact factor: 29.690

5.  Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Authors:  Venkatesh L Murthy; Timothy M Bateman; Rob S Beanlands; Daniel S Berman; Salvador Borges-Neto; Panithaya Chareonthaitawee; Manuel D Cerqueira; Robert A deKemp; E Gordon DePuey; Vasken Dilsizian; Sharmila Dorbala; Edward P Ficaro; Ernest V Garcia; Henry Gewirtz; Gary V Heller; Howard C Lewin; Saurabh Malhotra; April Mann; Terrence D Ruddy; Thomas H Schindler; Ronald G Schwartz; Piotr J Slomka; Prem Soman; Marcelo F Di Carli
Journal:  J Nucl Med       Date:  2017-12-14       Impact factor: 10.057

6.  Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?

Authors:  R S Beanlands; R deKemp; A Scheffel; C Nahmias; E S Garnett; G Coates; H L Johansen; E Fallen
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

7.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

8.  Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia.

Authors:  Brian J Page; Michael D Banas; Gen Suzuki; Brian R Weil; Rebeccah F Young; James A Fallavollita; Beth A Palka; John M Canty
Journal:  J Am Coll Cardiol       Date:  2015-02-24       Impact factor: 24.094

9.  Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease.

Authors:  Dipan J Shah; Han W Kim; Olga James; Michele Parker; Edwin Wu; Robert O Bonow; Robert M Judd; Raymond J Kim
Journal:  JAMA       Date:  2013-03-06       Impact factor: 56.272

10.  In vivo assessment of myocardial viability after acute myocardial infarction: A head-to-head comparison of the perfusable tissue index by PET and delayed contrast-enhanced CMR.

Authors:  Stefan A J Timmer; Paul F A Teunissen; Ibrahim Danad; Lourens F H J Robbers; Pieter G H M Raijmakers; Robin Nijveldt; Albert C van Rossum; Adriaan A Lammertsma; Niels van Royen; Paul Knaapen
Journal:  J Nucl Cardiol       Date:  2016-02-02       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.